BriaCell Therapeutics Corp (BCTXW) — Cash Flow Quality Index
Latest as of April 2024:
-3.00x
BriaCell Therapeutics Corp (BCTXW) has a Cash Flow Quality Index of -3.00x as of April 2024. Operating cash flow of $-5.08 Million is below net income of $1.69 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore BriaCell Therapeutics Corp cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
-3.00x
Operating CF / Net Income
Operating Cash Flow
$-5.08 Million
USD
Net Income
$1.69 Million
USD
Data as of
Apr 2024
Most recent filing
Annual Cash Flow Quality Index for BriaCell Therapeutics Corp (None–None)
Year-by-year earnings quality comparison for BriaCell Therapeutics Corp.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.